TikTok Content Creators Driving Unofficial Trade for Unapproved Weight-Loss Drug

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting products of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Material Elimination

Based on the social media company, the service has taken down problematic content and prohibited related keywords and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

Within moments of entering one group, a seller posted WhatsApp details, where most purchases take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Item Details and Costs

Inside these communities, posts show black plastic parcels with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to potentially significant health risks”.